Podcast brought to you by: Ingenuity Variant Analysis - Identify causal variants from human sequencing data in just hours.
Erik Holmlin, PhD, CEO, BioNano Genomics Bio and Contact Info
Listen (4:46) There is a lot of information lost with short read technology
Listen (5:06) What is an example of the practical impact of structural perspective?
Listen (8:49) Is it possible to have one platform that is good at short read and structural view?
Listen (11:28) From the clinic back to the tools space to persue the bottleneck
Listen (1:40) Thoughts on Moleculo
With all the advancement in next gen sequencing, have we actually been missing something important? Erik Holmlin thinks so. He's the CEO of BioNano Genomics, and he's left a career delivering diagnostics to the clinic to go back into the tools space and develop a new sequencing technology that would give a better structural view of the human genome. "I believe, broadly speaking, that the bottleneck in genomic medicine is unique and clinically significant genomic content. And the reason we don't have that is we don't have all the tools that scientists need. So I'm trying to develop those tools." That is a bold statement. In today's interview, I ask Holmlin if there is a new NGS Gospel to be spread?